AA
32
-3
ABT
59
-6
KEY
60
2
GPC
47
3
WEC
63
-2
DHR
52
2
TRV
52
2
CB
47
-4
EOG
39
-2
HUM
30
-6
SYK
46
-2
GME
91
8
ZTS
33
2
RHI
28
4
PNC
63
2
ADP
76
-3
GOOG
75
10
NUE
34
-3
SWKS
48
-5
HRB
52
-2
AA
32
-3
ABT
59
-6
KEY
60
2
GPC
47
3
WEC
63
-2
DHR
52
2
TRV
52
2
CB
47
-4
EOG
39
-2
HUM
30
-6
SYK
46
-2
GME
91
8
ZTS
33
2
RHI
28
4
PNC
63
2
ADP
76
-3
GOOG
75
10
NUE
34
-3
SWKS
48
-5
HRB
52
-2
Financhill
Back

Bionano Genomics 10K Form

Sell
39

BNGO
Bionano Genomics

Last Price:
$3.73
Seasonality Move:
12.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNGO News And Ratings

See the #1 stock for the next 7 days that we like better than BNGO

BNGO Financial Statistics

Sales & Book Value

Annual Sales: $30.8M
Cash Flow: $-2.8M
Price / Cash Flow: 0
Annual Sales: $15.54
Price / Book: 0.26

Profitability

EPS (TTM): -467.93860
Net Income (TTM): $-83.7M
Gross Margin: $380K
Return on Equity: -141.6%
Return on Assets: -78.99%

Bionano Genomics Earnings Forecast

Key Bionano Genomics Financial Ratios

  • The Gross Profit Margin over the past 9 years for BNGO is 1.23%.
  • The Selling, General & Administrative Expenses for BNGO have been equal to 168.49% of Gross Profit Margin.
  • The Research & Development expenses have been 80.59% of Revenue.
  • The Net Earning history of BNGO is -363.98% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Bionano Genomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BNGO
CUSIP: 09075F
Website: bionano.com

Debt

Debt-to-Equity Ratio: 0.27
Current Ratio: 1.7
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BNGO Technical Analysis vs Fundamental Analysis

Sell
39
Bionano Genomics (BNGO) is a Sell

Is Bionano Genomics a Buy or a Sell?

  • Bionano Genomics stock is rated a Sell
    The current Bionano Genomics [BNGO] share price is $3.77. The Score for BNGO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.